1.Mesenchymal stem cell therapy for acute respiratory distress syndrome: from basic to clinics.
Protein & Cell 2020;11(10):707-722
		                        		
		                        			
		                        			The 2019 novel coronavirus disease (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has occurred in China and around the world. SARS-CoV-2-infected patients with severe pneumonia rapidly develop acute respiratory distress syndrome (ARDS) and die of multiple organ failure. Despite advances in supportive care approaches, ARDS is still associated with high mortality and morbidity. Mesenchymal stem cell (MSC)-based therapy may be an potential alternative strategy for treating ARDS by targeting the various pathophysiological events of ARDS. By releasing a variety of paracrine factors and extracellular vesicles, MSC can exert anti-inflammatory, anti-apoptotic, anti-microbial, and pro-angiogenic effects, promote bacterial and alveolar fluid clearance, disrupt the pulmonary endothelial and epithelial cell damage, eventually avoiding the lung and distal organ injuries to rescue patients with ARDS. An increasing number of experimental animal studies and early clinical studies verify the safety and efficacy of MSC therapy in ARDS. Since low cell engraftment and survival in lung limit MSC therapeutic potentials, several strategies have been developed to enhance their engraftment in the lung and their intrinsic, therapeutic properties. Here, we provide a comprehensive review of the mechanisms and optimization of MSC therapy in ARDS and highlighted the potentials and possible barriers of MSC therapy for COVID-19 patients with ARDS.
		                        		
		                        		
		                        		
		                        			Adoptive Transfer
		                        			;
		                        		
		                        			Alveolar Epithelial Cells
		                        			;
		                        		
		                        			pathology
		                        			;
		                        		
		                        			Animals
		                        			;
		                        		
		                        			Apoptosis
		                        			;
		                        		
		                        			Betacoronavirus
		                        			;
		                        		
		                        			Body Fluids
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			CD4-Positive T-Lymphocytes
		                        			;
		                        		
		                        			immunology
		                        			;
		                        		
		                        			Clinical Trials as Topic
		                        			;
		                        		
		                        			Coinfection
		                        			;
		                        		
		                        			prevention & control
		                        			;
		                        		
		                        			therapy
		                        			;
		                        		
		                        			Coronavirus Infections
		                        			;
		                        		
		                        			complications
		                        			;
		                        		
		                        			immunology
		                        			;
		                        		
		                        			Disease Models, Animal
		                        			;
		                        		
		                        			Endothelial Cells
		                        			;
		                        		
		                        			pathology
		                        			;
		                        		
		                        			Extracorporeal Membrane Oxygenation
		                        			;
		                        		
		                        			Genetic Therapy
		                        			;
		                        		
		                        			methods
		                        			;
		                        		
		                        			Genetic Vectors
		                        			;
		                        		
		                        			administration & dosage
		                        			;
		                        		
		                        			therapeutic use
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Immunity, Innate
		                        			;
		                        		
		                        			Inflammation Mediators
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			Lung
		                        			;
		                        		
		                        			pathology
		                        			;
		                        		
		                        			physiopathology
		                        			;
		                        		
		                        			Mesenchymal Stem Cell Transplantation
		                        			;
		                        		
		                        			methods
		                        			;
		                        		
		                        			Mesenchymal Stem Cells
		                        			;
		                        		
		                        			physiology
		                        			;
		                        		
		                        			Multiple Organ Failure
		                        			;
		                        		
		                        			etiology
		                        			;
		                        		
		                        			prevention & control
		                        			;
		                        		
		                        			Pandemics
		                        			;
		                        		
		                        			Pneumonia, Viral
		                        			;
		                        		
		                        			complications
		                        			;
		                        		
		                        			immunology
		                        			;
		                        		
		                        			Respiratory Distress Syndrome, Adult
		                        			;
		                        		
		                        			immunology
		                        			;
		                        		
		                        			pathology
		                        			;
		                        		
		                        			therapy
		                        			;
		                        		
		                        			Translational Medical Research
		                        			
		                        		
		                        	
3.A Novel Porcine Model of Septic Shock Induced by Acute Respiratory Distress Syndrome due to Methicillin-resistant.
Shuo WANG ; Jun-Yu WANG ; Tao WANG ; Chen-Chen HANG ; Rui SHAO ; Chun-Sheng LI
Chinese Medical Journal 2017;130(10):1226-1235
BACKGROUNDSepsis is one of the main causes of mortality in critically ill patients following progression to septic shock. To investigate the pathophysiologic changes of sepsis, we developed a novel porcine model of septic shock induced by acute respiratory distress syndrome (ARDS) due to methicillin-resistant Staphylococcus aureus(MRSA) pneumonia.
METHODSTwenty-six male Landraces (Lvyuanweiye, Beijing, China) weighing 30 ± 2 kg were divided into four groups: sham group (SH; n = 5); cotton smoke inhalation group (SM; n = 6); MRSA pneumonia group (MR; n = 6); and septic shock group with cotton smoke inhalation + MRSA pneumonia (SS; n = 9). Extensive hemodynamics, oxygen dynamics, and lung function were monitored for 24 h following the injury or until death. Tissues were collected, and histopathology evaluations were carried out.
RESULTSBlood cultures from 6 of 9 animals in the SS group were positive for MRSA. Two hours following the injury, decreased mean arterial blood pressure (60-70 mmHg) and cardiac index (<2 L.min-1.m-2) were observed in the animals in the SS group, while systemic vascular resistance index was increased. The hemodynamic characteristics of septic shock were only observed in the SS group but not significant in the other groups. The PO2/FiO2in the SM and SS groups decreased to 300 and 100, respectively. In the SS group, extravascular lung water index increased to 20 ml/kg, whereas thoracopulmonary compliance decreased to 10 ml/H2O after injury. Deterioration of pulmonary function in the SS group was more serious than the SM and MR groups. Severe lung injury in the SS group was confirmed by the histopathology evaluations. The lung injury confirmed by high-resolution thin-section computed tomography and histopathology in the SS group was more serious than those of other groups.
CONCLUSIONSIn the present study, we developed a novel porcine model of septic shock induced by ARDS due to severe MRSA pneumonia with characteristic hyperdynamic and hypodynamic phases in 24 h, which mimicked the hemodynamic changing of septic shock in human.
Animals ; Disease Models, Animal ; Hemodynamics ; physiology ; Male ; Methicillin-Resistant Staphylococcus aureus ; pathogenicity ; Pneumonia ; microbiology ; pathology ; Respiratory Distress Syndrome, Adult ; complications ; pathology ; Shock, Septic ; etiology ; pathology ; Swine
4.Analysis of complications in 61 extracorporeal membrane oxygenation cases.
Xin CHANG ; Xin LI ; Zhen GUO ; Lingfeng XU ; Lin SUN ; Dan SHI ; Hua XU
Chinese Journal of Surgery 2016;54(5):384-388
OBJECTIVETo analyze the reason and treatment of the complications of 61 cases of extracorporeal membrane oxygenation (ECMO) in order to improve survival rate of ECMO treatment.
METHODSECMO records from January 2007 to December 2014 in Shanghai Chest Hospital were investigated retrospectively focusing on complications. There were included 43 male and 18 female patients, age 3 to 66 years. Indications for ECMO included post-operative low cardiac output, viral myocarditis, bridge to heart transplantation, acute respiratory distress syndrome and myocardial infarction. There were 49 cases of veno-arterial ECMO and 12 cases of veno-venous ECMO.
RESULTSECMO duration was 2 to 61 days. Among 43 patients, 37 patients weaned from ECMO successfully and 28 survived to discharge. Various complications occurred to 56 patients, including oxygenator plasma leakage(4 case times), circuit emboli (7), hemolysis (4), bleeding (34), infection (8), acute kidney injury (35), lower limb ischemia (8) and neurologic complications (6). There were 49 cases times of complications in survivors, while 61 cases times in death group. Bleeding (10 time cases) and acute kidney injury (33 time cases) happened in the death group. Progresses in ECMO technique had influences on complications in some parts. For instance, incidence of lower limb ischemia was 6/7 in cutdown cannulating group, but reduced to 2/42(4.8%) when semi-open technique was applied.
CONCLUSIONSComplications in ECMO are relative to patients' outcome intimately. Appropriate prevention and treatment of complication play a major role in the success of ECMO support. The incidences of certain complications reduce significantly due to progresses of equipment and medical experiences.
Acute Disease ; Acute Kidney Injury ; etiology ; Adolescent ; Adult ; Aged ; Child ; Child, Preschool ; China ; Extracorporeal Membrane Oxygenation ; adverse effects ; Female ; Heart Transplantation ; Hemorrhage ; etiology ; Humans ; Male ; Middle Aged ; Myocardial Infarction ; Myocarditis ; virology ; Respiratory Distress Syndrome, Adult ; Retrospective Studies ; Treatment Outcome ; Young Adult
5.A Child with Rapid-onset Respiratory Distress after Chemotherapy, Lung Irriadiation, General Anaesthesia, and Blood Transfusion.
Annals of the Academy of Medicine, Singapore 2015;44(11):548-549
		                        		
		                        		
		                        		
		                        			Abdominal Neoplasms
		                        			;
		                        		
		                        			complications
		                        			;
		                        		
		                        			secondary
		                        			;
		                        		
		                        			therapy
		                        			;
		                        		
		                        			Acute Lung Injury
		                        			;
		                        		
		                        			diagnostic imaging
		                        			;
		                        		
		                        			etiology
		                        			;
		                        		
		                        			Anemia
		                        			;
		                        		
		                        			complications
		                        			;
		                        		
		                        			therapy
		                        			;
		                        		
		                        			Antineoplastic Combined Chemotherapy Protocols
		                        			;
		                        		
		                        			therapeutic use
		                        			;
		                        		
		                        			Child, Preschool
		                        			;
		                        		
		                        			Etoposide
		                        			;
		                        		
		                        			administration & dosage
		                        			;
		                        		
		                        			Fluoroscopy
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Ifosfamide
		                        			;
		                        		
		                        			administration & dosage
		                        			;
		                        		
		                        			Kidney Neoplasms
		                        			;
		                        		
		                        			pathology
		                        			;
		                        		
		                        			Lung Neoplasms
		                        			;
		                        		
		                        			complications
		                        			;
		                        		
		                        			secondary
		                        			;
		                        		
		                        			therapy
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Postoperative Complications
		                        			;
		                        		
		                        			diagnostic imaging
		                        			;
		                        		
		                        			etiology
		                        			;
		                        		
		                        			Prosthesis Implantation
		                        			;
		                        		
		                        			Radiography, Thoracic
		                        			;
		                        		
		                        			Radiotherapy
		                        			;
		                        		
		                        			Respiratory Distress Syndrome, Adult
		                        			;
		                        		
		                        			diagnostic imaging
		                        			;
		                        		
		                        			etiology
		                        			;
		                        		
		                        			Transfusion Reaction
		                        			;
		                        		
		                        			Vascular Access Devices
		                        			
		                        		
		                        	
6.Lack of Efficacy of Ulinastatin Therapy During Cardiopulmonary Bypass Surgery.
Yan QIU ; Jing LIN ; Yang YANG ; Jing ZHOU ; Li-Na GONG ; Zhen QIN ; Lei DU
Chinese Medical Journal 2015;128(23):3138-3142
BACKGROUNDIt was believed that inflammatory response induced by cardiopulmonary bypass (CPB) was blamed for complications after cardiac surgery. To improve the outcome, many pharmacological interventions have been applied to attenuate inflammatory response during CPB. The objective of this study was to investigate the effect of ulinastatin (urinary trypsin inhibitor [UTI]) on outcome after CPB surgery.
METHODSTotally, 208 patients undergoing elective valves replacement between November 2013 and September 2014 were divided into Group U (n = 70) and Group C (n = 138) based on they received UTI or not. Categorical variables were compared between groups using Fisher's exact test, and continuous variables using unpaired Student's t-test or Mann-Whitney U-test. One-way analysis of variance and Dunnett's or Tukey's tests were used to compare values at different time points within the same group. The risk of outcomes was estimated and adjusted by multivariable logistic regression, propensity scoring, and mixed-effect models for all measured variables.
RESULTSBoth the serious complications in total, including death, acute lung injury, acute respiratory distress syndrome and acute kidney injury, and the other complications, including hemodialysis, infection, re-incubation, and tracheotomy were similar between the two groups (P > 0.05). After adjusted by multivariable logistic regression and the propensity score, UTI still cannot be found any benefit to improve any outcomes after cardiac surgery. Also, no statistical differences with regard to duration of postoperative mechanical ventilation, the length of Intensive Care Unit and hospital stays (P > 0.05).
CONCLUSIONUTI did not improve postoperative outcomes in our patients after cardiopulmonary bypass surgery.
Acute Kidney Injury ; etiology ; Adult ; Cardiac Surgical Procedures ; adverse effects ; Cardiopulmonary Bypass ; adverse effects ; Female ; Glycoproteins ; therapeutic use ; Humans ; Length of Stay ; Male ; Middle Aged ; Postoperative Complications ; Respiratory Distress Syndrome, Adult ; etiology ; Retrospective Studies
7.Bronchiolitis Obliterans Associated with Stevens-Johnson Syndrome: A Case Report.
Hyungchul PARK ; Young Bo KO ; Hyouk Soo KWON ; Chae Man LIM
Yonsei Medical Journal 2015;56(2):578-581
		                        		
		                        			
		                        			We report a case of bronchiolitis obliterans associated with Stevens-Johnson syndrome. A 59-year-old man presented with respiratory distress that gradually worsened over 3 months. He had been diagnosed with Stevens-Johnson syndrome 3 months before admission. He had no history of previous airway disease. On physical examination, expiratory breathing sounds were not audible, and a chest X-ray revealed a hyperinflated lung. A pulmonary function test indicated a severe obstructive pattern. Computed tomography scans of inspiratory and expiratory phases of respiration showed oligemia and air trapping, and both were more prominent on expiration view than on inspiration view. The pathogenesis of bronchiolitis obliterans associated with Stevens-Johnson syndrome is largely unknown.
		                        		
		                        		
		                        		
		                        			Anti-Bacterial Agents/therapeutic use
		                        			;
		                        		
		                        			Bronchiolitis Obliterans/etiology/*radiography/therapy
		                        			;
		                        		
		                        			Bronchoscopy
		                        			;
		                        		
		                        			Dyspnea/*complications
		                        			;
		                        		
		                        			Fatal Outcome
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Middle Aged
		                        			;
		                        		
		                        			Radiography, Thoracic
		                        			;
		                        		
		                        			Respiratory Distress Syndrome, Adult/*etiology/therapy
		                        			;
		                        		
		                        			Respiratory Function Tests
		                        			;
		                        		
		                        			Roxithromycin/therapeutic use
		                        			;
		                        		
		                        			Stevens-Johnson Syndrome/*complications/drug therapy
		                        			;
		                        		
		                        			Tomography, X-Ray Computed/methods
		                        			;
		                        		
		                        			Tracheostomy
		                        			
		                        		
		                        	
8.Application of Damage Control Resuscitation Strategies to Patients with Severe Traumatic Hemorrhage: Review of Plasma to Packed Red Blood Cell Ratios at a Single Institution.
Younghwan KIM ; Kiyoung LEE ; Jihyun KIM ; Jiyoung KIM ; Yunjung HEO ; Heejung WANG ; Kugjong LEE ; Kyoungwon JUNG
Journal of Korean Medical Science 2014;29(7):1007-1011
		                        		
		                        			
		                        			When treating trauma patients with severe hemorrhage, massive transfusions are often needed. Damage control resuscitation strategies can be used for such patients, but an adequate fresh frozen plasma: packed red blood cell (FFP:PRBC) administration ratio must be established. We retrospectively reviewed the medical records of 100 trauma patients treated with massive transfusions from March 2010 to October 2012. We divided the patients into 2 groups according to the FFP:PRBC ratio: a high-ratio (> or =0.5) and a low-ratio group (<0.5). The patient demographics, fluid and transfusion quantities, laboratory values, complications, and outcomes were analyzed and compared. There were 68 patients in the high-ratio and 32 in the low-ratio group. There were statistically significant differences between groups in the quantities of FFP, FFP:PRBC, platelets, and crystalloids administered, as well as the initial diastolic blood pressure. Bloodstream infections were noted only in the high-ratio group, and the difference was statistically significant (P=0.028). Kaplan-Meier plots revealed that the 24-hr survival rate was significantly higher in the high-ratio group (71.9% vs. 97.1%, P<0.001). In severe hemorrhagic trauma, raising the FFP:PRBC ratio to 0.5 or higher may increase the chances of survival. Efforts to minimize bloodstream infections during the resuscitation must be increased.
		                        		
		                        		
		                        		
		                        			Acute Lung Injury/epidemiology/etiology
		                        			;
		                        		
		                        			Adolescent
		                        			;
		                        		
		                        			Adult
		                        			;
		                        		
		                        			Aged
		                        			;
		                        		
		                        			Aged, 80 and over
		                        			;
		                        		
		                        			Bacterial Infections/epidemiology
		                        			;
		                        		
		                        			*Blood Transfusion/adverse effects
		                        			;
		                        		
		                        			*Erythrocyte Transfusion/adverse effects
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Hemorrhage/etiology/*prevention & control
		                        			;
		                        		
		                        			Hospital Mortality
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Kaplan-Meier Estimate
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Middle Aged
		                        			;
		                        		
		                        			Patients
		                        			;
		                        		
		                        			Respiratory Distress Syndrome, Adult/epidemiology/etiology
		                        			;
		                        		
		                        			Resuscitation
		                        			;
		                        		
		                        			Retrospective Studies
		                        			;
		                        		
		                        			Wounds and Injuries/complications/mortality/*therapy
		                        			;
		                        		
		                        			Young Adult
		                        			
		                        		
		                        	
10.Acute respiratory distress syndrome in the pediatric age: an update on advanced treatment.
Giuseppe A MARRARO ; Chengshui CHEN ; Maria Antonella PIGA ; Yan QIAN ; Claudio SPADA ; Umberto GENOVESE
Chinese Journal of Contemporary Pediatrics 2014;16(5):437-447
		                        		
		                        			
		                        			Acute respiratory distress syndrome (ARDS) is a heterogeneous syndrome that lacks definitive treatment. The cornerstone of management is sound intensive care treatment and early anticipatory ventilation support. A mechanical ventilation strategy aiming at optimal alveolar recruitment, judicious use of positive end-respiratory pressure (PEEP) and low tidal volumes (VT) remains the mainstay for managing this lung disease. Several treatments have been proposed in rescue settings, but confirmation is needed from large controlled clinical trials before they be recommended for routine care. Non-invasive ventilation (NIV) is suggested with a cautious approach and a strict selection of candidates for treatment. Mild and moderate cases can be efficiently treated by NIV, but this is contra-indicated with severe ARDS. The extra-corporeal carbon dioxide removal (ECCO2 R), used as an integrated tool with conventional ventilation, is playing a new role in adjusting respiratory acidosis and CO2. The proposed benefits of ECCO2 R over extra-corporeal membrane oxygenation (ECMO) consist in a reduction of artificial surface contact, avoidance of pump-related side effects and technical complications, as well as lower costs. The advantages and disadvantages of inhaled nitric oxide (iNO) are better recognized today and iNO is not recommended for ARDS and acute lung injury (ALI) in children and adults because iNO results in a transient improvement in oxygenation but does not reduce mortality, and may be harmful. Several trials have found no clinical benefit from various surfactant supplementation methods in adult patients with ARDS. However, studies which are still controversial have shown that surfactant supplementation can improve oxygenation and decrease mortality in pediatric and adolescent patients in specific conditions and, when applied in different modes and doses, also in neonatal respiratory distress syndrome (RDS) of preemies. Management of ARDS remains supportive, aimed at improving gas exchange and preventing complications. Progress in the treatment of ARDS must be addressed toward the new paradigm of the disease pathobiology to be applied to the disease definition and to predict the treatment outcome, also with the perspective to develop predictive and personalized medicine that highlights new and challenging opportunities in terms of benefit for patient's safety and doctor's responsibility, with further medico-legal implication.
		                        		
		                        		
		                        		
		                        			Child
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Nitric Oxide
		                        			;
		                        		
		                        			administration & dosage
		                        			;
		                        		
		                        			Noninvasive Ventilation
		                        			;
		                        		
		                        			Positive-Pressure Respiration
		                        			;
		                        		
		                        			Prone Position
		                        			;
		                        		
		                        			Pulmonary Atelectasis
		                        			;
		                        		
		                        			etiology
		                        			;
		                        		
		                        			Pulmonary Surfactants
		                        			;
		                        		
		                        			therapeutic use
		                        			;
		                        		
		                        			Respiratory Distress Syndrome, Adult
		                        			;
		                        		
		                        			therapy
		                        			
		                        		
		                        	
            
Result Analysis
Print
Save
E-mail